Alpha Tau Valuation
| DRTS Stock | USD 6.96 0.02 0.29% |
At this time, the firm appears to be undervalued. Alpha Tau Medical shows a prevailing Real Value of $7.26 per share. The current price of the firm is $6.96. Our model approximates the value of Alpha Tau Medical from analyzing the firm fundamentals such as Current Valuation of 534.73 M, shares owned by insiders of 32.70 %, and Return On Equity of -0.54 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Alpha Tau's valuation include:
Undervalued
Today
Please note that Alpha Tau's price fluctuation is moderately volatile at this time. Calculation of the real value of Alpha Tau Medical is based on 3 months time horizon. Increasing Alpha Tau's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Alpha stock is determined by what a typical buyer is willing to pay for full or partial control of Alpha Tau Medical. Since Alpha Tau is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alpha Stock. However, Alpha Tau's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.96 | Real 7.26 | Target 8.25 | Hype 7.0 | Naive 6.55 |
The intrinsic value of Alpha Tau's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alpha Tau's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alpha Tau Medical helps investors to forecast how Alpha stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alpha Tau more accurately as focusing exclusively on Alpha Tau's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alpha Tau's intrinsic value based on its ongoing forecasts of Alpha Tau's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alpha Tau's closest peers.
Alpha Tau Cash |
|
Alpha Tau Total Value Analysis
Alpha Tau Medical is currently anticipated to have valuation of 534.73 M with market capitalization of 622.43 M, debt of 12.54 M, and cash on hands of 112.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alpha Tau fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
534.73 M | 622.43 M | 12.54 M | 112.04 M |
Alpha Tau Asset Utilization
One of the ways to look at asset utilization of Alpha is to check how much profit was generated for every dollar of assets it reports. Alpha Tau Medical shows a negative utilization of assets of -0.26 percent, losing $0.002556 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Alpha Tau Medical shows how discouraging it operates for each dollar spent on its assets.Alpha Tau Profitability Analysis
Based on Alpha Tau's profitability indicators, Alpha Tau Medical may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Alpha Tau's ability to earn profits and add value for shareholders.Net Loss | First Reported 2019-03-31 | Previous Quarter -10.1 M | Current Value -11.7 M | Quarterly Volatility 5.1 M |
For Alpha Tau profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Alpha Tau Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Alpha Tau utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Alpha Tau's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Alpha Tau over time as well as its relative position and ranking within its peers.
Alpha Tau Earnings per Share Projection vs Actual
The next projected EPS of Alpha Tau is estimated to be -0.12 with future projections ranging from a low of -0.13 to a high of -0.11. Alpha Tau's most recent 12-month trailing earnings per share (EPS TTM) is at -0.55. Please be aware that the consensus of earnings estimates for Alpha Tau Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.Alpha Tau Earnings Estimation Breakdown
The calculation of Alpha Tau's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Alpha Tau is estimated to be -0.12 with the future projection ranging from a low of -0.13 to a high of -0.11. Please be aware that this consensus of annual earnings estimates for Alpha Tau Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.13 Lowest | Expected EPS | -0.11 Highest |
Alpha Tau Earnings Projection Consensus
Suppose the current estimates of Alpha Tau's value are higher than the current market price of the Alpha Tau stock. In this case, investors may conclude that Alpha Tau is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Alpha Tau's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 4 | 67.85% | 0.0 | -0.12 | -0.55 |
Alpha Tau Ownership Allocation
Alpha Tau holds a total of 85.26 Million outstanding shares. Alpha Tau Medical retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alpha Tau Profitability Analysis
Net Loss for the year was (31.75 M) with profit before overhead, payroll, taxes, and interest of 0.About Alpha Tau Valuation
The stock valuation mechanism determines Alpha Tau's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Alpha Tau Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alpha Tau. We calculate exposure to Alpha Tau's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alpha Tau's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -991.8 K | -1 M |
Alpha Tau Current Valuation Indicators
Alpha Tau's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alpha Tau's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alpha Tau, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alpha Tau's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alpha Tau's worth.Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.